Skip to content
Cognate BioServices, a Charles River Company logo — Your CDMO Partner from Concept to Commercial for Cell & Gene...

Cognate BioServices, a Charles River Company

Your CDMO Partner from Concept to Commercial for Cell & Gene Therapy Products

Founded 2002 United States Memphis, United States 81 employees Series B Biotechnology, Health Care +1

General Information

Company Name Cognate BioServices, a Charles River Company
Founded Year 2002
Location United States Memphis, United States
Founders / Decision Makers
Team member
Employees 81
Industries Biotechnology, Health Care, Manufacturing
Funding Stage Series B
Social

BounceWatch is an independent company data service, not affiliated with Cognate BioServices, a Charles River Company. To contact Cognate BioServices, a Charles River Company, visit cognatebioservices.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Cognate BioServices, a Charles River Company compare?

A PDF of Cognate BioServices, a Charles River Company and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Cognate BioServices, a Charles River Company soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Cognate BioServices, a Charles River Company

Cognate BioServices, founded in 2002, is a leading contract development and manufacturing organization specialized in cell and cell-mediated gene therapies. The company's slogan, "Your CDMO Partner from Concept to Commercial for Cell & Gene Therapy Products," encapsulates its mission. With a focus on providing a broad range of commercialization services to regenerative medicine, cellular immunotherapy, and advanced cell therapy companies, Cognate offers a unique combination of custom services across all points of clinical and commercial development. This includes early preclinical studies, mid-phase trials, product scale-up, later-stage clinical trials, and bridging into commercial manufacturing. Based in the United States, Cognate BioServices has garnered attention with its most recent Series B investment on 21 January 2020. Noteworthy investors in this round included EW Healthcare Partners and Medivate Partners. As an organization that prides itself on its quality and experience, Cognate applies the know-how and expertise of its business, scientific, and technical teams to successfully develop autologous and allogeneic products across multiple cell-based technology platforms, from start to finish. With a strong focus on biotechnology, health care, and manufacturing industries, Cognate BioServices continues to play a pivotal role in advancing cell and gene therapies for the betterment of medical science.

Business keywords: CDMO, contract development and manufacturing organization, cell therapy, gene therapy, regenerative medicine, immunotherapy, cGMP manufacturing, autologous products, allogeneic products, cell-based technology, preclinical studies, clinical trials, commercial development, biopharmaceuticals, scientific expertise

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Series B Undisclosed 2
Medivate Partners, Essex Woodlands Healthcare Partners
21 Jan 2020
Venture Round Undisclosed 1
Essex Woodlands Healthcare Partners
26 Aug 2019
Venture Round Undisclosed 2
Medivate Partners, Tennenbaum Capital Partners
20 Feb 2018

Cognate BioServices, a Charles River Company Alternatives & Competitors

View All Alternatives
Cognate BioServices, a Charles River Company vs
RoslinCT
RoslinCT United Kingdom

Your Advanced Cell & Gene Therapy CDMO Partner

Private Equity
350 employees
Biotechnology, Manufacturing
Cognate BioServices, a Charles River Company vs
Excellos
Excellos United States

A unique full-service CDMO, setting new standards in Cell & Gene Therapy

Corporate Round
38 employees
Biotechnology, Health Care
Cognate BioServices, a Charles River Company vs

End-to-end ATMP CDMO/CRO that provides innovative offerings at each stage for biopharmaceutical prod...

Series B
46 employees
Biotechnology, Health and Wellness

FAQ About Cognate BioServices, a Charles River Company

Your CDMO Partner from Concept to Commercial for Cell & Gene Therapy Products
Cognate BioServices, a Charles River Company was founded in 2002.
Cognate BioServices, a Charles River Company is headquartered in Memphis, United States.
Cognate BioServices, a Charles River Company operates in Biotechnology, Health Care and Manufacturing. Its work centres on CDMO, contract development and manufacturing organization, cell therapy and gene therapy.
Cognate BioServices, a Charles River Company has approximately 81 employees.
Cognate BioServices, a Charles River Company has completed 3 funding rounds. The latest funding stage is Series B.
Top alternatives and competitors to Cognate BioServices, a Charles River Company include RoslinCT, Excellos, Porton Advanced | ATMP CDMO/CRO, IDT Biologika, China Regenerative Medicine International. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Cognate BioServices, a Charles River Company and RoslinCT are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Cognate BioServices, a Charles River Company, https://bouncewatch.com/company/cognate-bioservices, updated 30 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout